Emergent BioSolutions has been granted a patent for polynucleotides encoding multi-epitope polypeptides to treat Toxoplasma gondii infection. The patent includes an isolated polynucleotide encoding a chimeric polypeptide. GlobalData’s report on Emergent BioSolutions gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
According to GlobalData’s company profile on Emergent BioSolutions, LPS antibody-based anti-bacterials was a key innovation area identified from patents. Emergent BioSolutions's grant share as of May 2024 was 31%. Grant share is based on the ratio of number of grants to total number of patents.
Treatment for toxoplasma gondii infection using chimeric polypeptides
A recently granted patent (Publication Number: US11969465B2) discloses an isolated polynucleotide encoding a chimeric polypeptide. This chimeric polypeptide includes specific amino acid sequences and may further contain a peptide domain that promotes self-assembly or multimerization. The patent also covers the inclusion of a secretory signal at the N-terminus of the chimeric polypeptide, enhancing its functionality.
Moreover, the patent extends to a recombinant expression vector incorporating the isolated polynucleotide, linked to a control sequence. Additionally, a pharmaceutical composition is detailed, comprising the isolated polynucleotide encoding the chimeric polypeptide along with a pharmaceutically acceptable carrier. The composition may also include an adjuvant, further enhancing its pharmaceutical properties.
To know more about GlobalData’s detailed insights on Emergent BioSolutions, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
